Timing of sodium-glucose cotransporter 2 inhibitor initiation and post-discharge outcomes in acute heart failure with diabetes: A population-based cohort study

被引：1
|
作者：
Wu, Che-Yuan [1 ,2 ]
Shah, Baiju R. [3 ,4 ,5 ]
Sharma, Abhinav [6 ,7 ]
Sheng, Yiru [3 ]
Liu, Peter P. [8 ]
Kopp, Alexander [3 ]
Saskin, Refik [3 ]
Edwards, Jodi D. [8 ,9 ,10 ]
Swardfager, Walter [1 ,2 ,11 ]
机构：
[1] Univ Toronto, Dept Pharmacol & Toxicol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada
[2] Sunnybrook Res Inst, Dr Sandra Black Ctr Brain Resilience & Recovery, Hurvitz Brain Sci Program, Toronto, ON, Canada
[3] ICES, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Med, Div Endocrinol, Toronto, ON, Canada
[5] Univ Toronto, Dept Med, Toronto, ON, Canada
[6] McGill Univ, Hlth Ctr, Div Cardiol, Montreal, PQ, Canada
[7] McGill Univ, Hlth Ctr, DREAM CV Lab, Montreal, PQ, Canada
[8] Univ Ottawa, Heart Inst, Ottawa, ON, Canada
[9] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
[10] ICES UOttawa, Ottawa, ON, Canada
[11] KITE Univ Hlth Network Toronto Rehabil Inst, Toronto, ON, Canada
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2025年 / 27卷 / 02期
基金：
加拿大健康研究院;
关键词：
Acute heart failure; Diabetes; SGLT2; inhibitor; Pharmacoepidemiology; IMPACT; RISK;
D O I：
10.1002/ejhf.3464
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sodium-glucose cotransporter 2 (SGLT2) inhibitors in acute heart failure. image
引用
收藏
页码：307 / 316
页数：10
相关论文
共 50 条
  • [41] Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study
    Engstroem, Arvid
    Wintzell, Viktor
    Melbye, Mads
    Hviid, Anders
    Eliasson, Bjoern
    Gudbjoernsdottir, Soffia
    Hveem, Kristian
    Jonasson, Christian
    Svanstroem, Henrik
    Pasternak, Bjoern
    Ueda, Peter
    DIABETES CARE, 2023, 46 (02) : 351 - 360
  • [42] A Clinical Study on the Association of Sodium-Glucose Cotransporter 2 Inhibitors and Acute Kidney Injury Among Diabetic Chinese Population
    Shen, Lianglan
    Yang, Hongli
    Fang, Xingxing
    Huang, Huaxing
    Yao, Wubin
    Chen, Dongmei
    Shen, Yan
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1621 - 1630
  • [43] Kidney Outcomes with Sodium-Glucose Cotransporter-2 Inhibitor Initiation after AKI among Veterans with Diabetic Kidney Disease
    Murphy, Daniel P.
    Wolfson, Julian
    Reule, Scott
    Johansen, Kirsten L.
    Ishani, Areef
    Drawz, Paul E.
    KIDNEY360, 2024, 5 (03): : 335 - 343
  • [44] Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population-based study of older women and men with diabetes
    Lega, Iliana C.
    Bronskill, Susan E.
    Campitelli, Michael A.
    Guan, Jun
    Stall, Nathan M.
    Lam, Kenneth
    McCarthy, Lisa M.
    Gruneir, Andrea
    Rochon, Paula A.
    DIABETES OBESITY & METABOLISM, 2019, 21 (11) : 2394 - 2404
  • [45] Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
    Salah, Husam M.
    Al'Aref, Subhi J.
    Khan, Muhammad Shahzeb
    Al-Hawwas, Malek
    Vallurupalli, Srikanth
    Mehta, Jawahar L.
    Mounsey, J. Paul
    Greene, Stephen J.
    McGuire, Darren K.
    Lopes, Renato D.
    Fudim, Marat
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [46] Sodium-glucose cotransporter 2 inhibitor-induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction
    Cavka, Luka
    Bencak Ferko, Urska
    Pitz, Natasa
    Trpkovski, Zoranco
    Lainscak, Mitja
    ESC HEART FAILURE, 2021, 8 (04): : 2631 - 2636
  • [47] Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Therapy for the Primary and Secondary Prevention of Heart Failure in Patients With and Without Type 2 Diabetes Mellitus: A Systematic Review
    Wahinya, Maureen
    Khan, Zahid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [48] New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: A nationwide population-based cohort study
    Cho, Yun Kyung
    Kim, Sehee
    Kim, Myung Jin
    Lee, Woo Je
    Kim, Ye-Jee
    Jung, Chang Hee
    DIABETES & METABOLISM, 2025, 51 (02)
  • [49] The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Is Placebo Assignment Justified in Patients With Comorbid Diabetes Mellitus and Heart Failure?
    Butler, Javed
    Anker, Stefan D.
    CIRCULATION, 2017, 136 (16) : 1459 - 1461
  • [50] Treatment with sodium-glucose cotransporter type 2 inhibitors in acute heart failure: review of the EMPULSE study and analysis of the literature
    Di Fusco, Stefania Angela
    Matteucci, Andrea
    Spinelli, Antonella
    Aquilani, Stefano
    Imperoli, Giuseppe
    Colivicchi, Furio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2024, 25 (12) : 875 - 884
12345